Uwe Schoenbeck
Venture Partner·Canaan Partners
Uwe Schoenbeck is a Venture Partner at Canaan, where he helps drive new healthcare investments and company creation using scientific and pharmaceutical R&D experience. Before Canaan, he was Senior Vice President and Chief Scientific Officer, Emerging Science & Innovation, in Pfizer’s Worldwide Development & Medical division. Earlier roles included Vice President, Emerging R&D Innovation at Wyeth and Vice President, Cardiovascular Research at Boehringer Ingelheim.
See the rest of Uwe Schoenbeck's profile.
Deal history, investment focus, outreach angles and the rest of the background. One email, no password — we send a link and you land right back here.